Af­ter pa­tient out­cry, Taysha starts to of­fload drug pro­grams

Taysha Gene Ther­a­pies has of­floaded some of the paused drugs in its pipeline, fol­low­ing near­ly two years of pres­sure from pa­tient groups who fund­ed ear­ly work on the pro­grams.

Thurs­day’s an­nounce­ment in­cludes three drug pro­grams that are be­ing sent back to uni­ver­si­ties, though a pa­tient group that jump­start­ed one of them has since moved on to de­vel­op­ing an­oth­er gene ther­a­py con­struct.

In a state­ment, Taysha said it’s ex­plor­ing part­ner­ships for oth­er paused pro­grams, but the com­pa­ny de­clined to say how many ad­di­tion­al drugs it’s look­ing to of­fload and the tim­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER